Vaginal oxygen plus hyaluronic acid on genito-urinary symptoms of breast cancer survivors

References

• Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249.
   PubMed Web of Science ®Google Scholar
• Azim HA, Jr, Partridge AH. Biology of breast cancer in young women. Breast Cancer Res. 2014;16:427.
   PubMed Web of Science ®Google Scholar
• Paluch-Shimon S, Cardoso F, Partridge AH, et al. ESO-ESMO 4th international consensus guidelines for breast cancer in young women (BCY4). Ann Oncol. 2020;31(6):674–696.
   PubMed Web of Science ®Google Scholar
• Francis PA, Pagani O, Fleming GF, et al. Tailoring adjuvant endocrine therapy for premenopausal breast cancer. N Engl J Med. 2018;379(2):122–137.
   PubMed Web of Science ®Google Scholar
• Franzoi MA, Agostinetto E, Perachino M, et al. Evidence-based approaches for the management of side-effects of adjuvant endocrine therapy in patients with breast cancer. Lancet Oncol. 2021;22(7):e303–e313.
   PubMed Web of Science ®Google Scholar
• Ekinci E, Nathoo S, Korattyil T, et al. Interventions to improve endocrine therapy adherence in breast cancer survivors: what is the evidence? J Cancer Surviv. 2018;12(3):348–356.
   PubMed Web of Science ®Google Scholar
• Portman DJ, Gass ML, Vulvovaginal Atrophy Terminology Consensus Conference Panel. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women’s Sexual Health and the North American Menopause Society. Menopause. 2014;21(10):1063–1068.
   PubMed Web of Science ®Google Scholar
• Baumgart J, Nilsson K, Stavreus-Evers A, et al. Urogenital disorders in women with adjuvant endocrine therapy after early breast cancer. Am J Obstet Gynecol. 2011;204(1):26.e1–26.e7.
   PubMed Web of Science ®Google Scholar
• Cagnacci A, Venier M, Xholli A, et al. Female sexuality and vaginal health across the menopausal age. Menopause. 2020;27(1):14–19.
   PubMed Web of Science ®Google Scholar
• Falk SJ, Bober S. Vaginal health during breast cancer treatment. Curr Oncol Rep. 2016;18(5):32.
   PubMed Web of Science ®Google Scholar
• Massarotti C, Scaruffi P, Lambertini M, et al. Beyond fertility preservation: role of the oncofertility unit in the reproductive and gynecological follow-up of young cancer patients. Hum Reprod. 2019;34(8):1462–1469.
   PubMed Web of Science ®Google Scholar
• Poggio F, Del Mastro L, Bruzzone M, et al. Safety of systemic hormone replacement therapy in breast cancer survivors: a systematic review and meta-analysis. Breast Cancer Res Treat. 2022;191(2):269–275.
   PubMed Web of Science ®Google Scholar
• ACOG Committee opinion no. 659: the use of vaginal estrogen in women with a history of estrogen-dependent breast cancer. Obstet Gynecol. 2016;127:e93–e96.
   PubMed Web of Science ®Google Scholar
• Carter J, Baser RE, Goldfrank DJ, et al. A single-arm, prospective trial investigating the effectiveness of a non-hormonal vaginal moisturizer containing hyaluronic acid in postmenopausal cancer survivors. Support Care Cancer. 2021;29(1):311–322.
   PubMed Web of Science ®Google Scholar
• Palma F, Xholli A, Cagnacci A, et al. Management of vaginal atrophy: a real mess. Results from the AGATA study. Gynecol Endocrinol. 2017;33(9):702–707.
   PubMed Web of Science ®Google Scholar
• D’Oria O, Giannini A, Buzzaccarini G, et al. Fractional CO2 laser for vulvo-vaginal atrophy in gynecologic cancer patients: a valid therapeutic choice? A systematic review. Eur J Obstet Gynecol Reprod Biol. 2022;277:84–89.
   PubMed Web of Science ®Google Scholar
• Li FG, Maheux-Lacroix S, Deans R, et al. Effect of fractional carbon dioxide laser vs sham treatment on symptom severity in women with postmenopausal vaginal symptoms: a randomized clinical trial. JAMA. 2021;326(14):1381–1389.
   PubMed Web of Science ®Google Scholar
• Condemi L, Di Giuseppe J, Delli Carpini G, et al. Vaginal natural oxygenation device (VNOD) for concomitant administration of hyaluronic acid and topical hyperbaric oxygen to treat vulvo-vaginal atrophy: a pilot study. Eur Rev Med Pharmacol Sci. 2018;22(23):8480–8486.
   PubMed Web of Science ®Google Scholar
• Particco M, Djumaeva S, Nappi RE, et al. The European Vulvovaginal Epidemiological Survey (EVES): impact on sexual function of vulvovaginal atrophy of menopause. Menopause. 2020;27(4):423–429.
   PubMed Web of Science ®Google Scholar
• Cagnacci A, Sclauzero M, Meriggiola C, et al. Lower urinary tract symptoms and their relation to vaginal atrophy in women across the menopausal age span. Results from the ANGEL multicentre observational study. Maturitas. 2020;140:8–13.
   PubMed Web of Science ®Google Scholar
• Cagnacci A, Barattini DF, Casolati E, et al. Polycarbophil vaginal moisturizing gel versus hyaluronic acid gel in women affected by vaginal dryness in late menopausal transition: a prospective randomized trial. Eur J Obstet Gynecol Reprod Biol. 2022;270:239–245.
   PubMed Web of Science ®Google Scholar
• Sheikh AY, Gibson JJ, Rollins MD, et al. Effect of hyperoxia on vascular endothelial growth factor levels in a wound model. Arch Surg. 2000;135(11):1293–1297.
   PubMedGoogle Scholar
• Younis I. Role of oxygen in wound healing. J Wound Care. 2020;29(Sup5b):S4–S10.
   PubMedGoogle Scholar
• Chen CA, Huang YC, Lo JJ, et al. Hyperbaric oxygen therapy attenuates burn-induced denervated muscle atrophy. Int J Med Sci. 2021;18(16):3821–3830.
   PubMed Web of Science ®Google Scholar
• Sinha A, Ewies AA. Non-hormonal topical treatment of vulvovaginal atrophy: an up-to-date overview. Climacteric. 2013;16(3):305–312.
   PubMed Web of Science ®Google Scholar
• Buzzaccarini G, Marin L, Noventa M, et al. Hyaluronic acid in vulvar and vaginal administration: evidence from a literature systematic review. Climacteric. 2021;24(6):560–571.
   PubMed Web of Science ®Google Scholar
• Dos Santos CCM, Uggioni MLR, Colonetti T, et al. Hyaluronic acid in postmenopause vaginal atrophy: a systematic review. J Sex Med. 2021;18(1):156–166.
   PubMed Web of Science ®Google Scholar
• Roy S, Caillouette JC, Roy T, et al. Vaginal pH is similar to follicle-stimulating hormone for menopause diagnosis. Am J Obstet Gynecol. 2004;190(5):1272–1277.
   PubMed Web of Science ®Google Scholar